eli lilly glp-1 news The FDA approved a new pill from on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication Lilly is selling $12.9 billion

It has been studied for promoting angiogenesis (new blood vessels), recruiting fibroblasts (the cells that rebuild connective tissue), and modulating growth-factor and nitric-oxide pathways together supporting local tissue repair

The G protein-coupled receptor of GLP-1 (GLP-1R) originally identified in islet -cells is widely expressed in extrapancreatic tissues as well including the lungs, kidney, brain, the enteric and peripheral nervous system, lymphocytes, smooth muscle cells (SMCs), and atrial cardiomyocytes [32] The specific identity of GLP-1 receptor-positive (GLP-1R+) cells in the heart remains uncertain

Conclusion The present study pointed to the protective effect of PA against APAP-induced hepatotoxicity in mice through ameliorating the functional, biochemical and morphological changes of APAP-induced hepatotoxicity

Chukkalore, D., MacDougall, K., Master, V., Bilen, M

Studies have identified an association between the medications and other eye conditions, including diabetic retinopathy and non-arteritic anterior ischemic optic neuropathy (NAION)